The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21.20 - Manufacture Of Pharmaceutical Preparations
70 jobs Number of planned job losses
Announcement Date
7 January 2025
Employment effect (start)
31 January 2025
Foreseen end date
Description
Univercells, a Belgian biotech company and group specialised in the development of vaccinations has announced it will restructure its facility in Gosselies. In total 73 of the 400 employees at the facility are facing dismissal.
The main reasoning behind the dismissal according to the company management are both related to the current economic situation as well as an overcapacity within the sector. As prescribed by the Renault-Law, the company management has started the consultation and information phase with the trade unions.
Eurofound (2025), Univercells, Internal restructuring in Belgium, factsheet number 202219, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/202219.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
